Patients, Pharmacists Tackle SDOH, With Surprising Insights
May 4th 2022At the Pharmacy Quality Alliance (PQA) 2022 Annual Meeting Wednesday, participants heard about some unexpected insights arising from a workshop held this week between patients and pharmacists who are creating a patient-centered outcomes research agenda focused on addressing social determinants of health (SDOH) in the community pharmacy setting.
Read More
Study Identifies Sleep Length Associated With Lowest Mortality Rate in Patients With T2D
May 4th 2022A recent study found a J-shaped association between sleep duration and mortality in people with type 2 diabetes (T2D), with a length of 5 to 7 hours associated with the lowest risk of mortality.
Read More
High Disability Burden of Atopic Dermatitis Linked With Socioeconomic Status
May 4th 2022Atopic dermatitis was associated with the greatest burden of disease compared with 2 other types of dermatitis, in which high incidence and disability-adjusted life-years rates corresponded with high sociodemographic index areas.
Read More
SES-Related Insulin Pump Uptake Disparities Seen in 2 Canadian Provinces
May 4th 2022Using socioeconomic status (SES) as their primary exposure, investigators from McGill University, University of Manitoba, Institut National de Santé Publique du Québec, and Laval University investigated reasons behind insulin pump uptake disparities in the Canadian provinces of Manitoba and Québec.
Read More
Half of US states are expected to restrict or ban abortion following the Supreme Court’s leaked draft majority opinion; Bayer’s darolutamide (Nubeqa) received FDA priority review as a treatment for metastatic hormone-sensitive prostate cancer; Biogen stops marketing its controversial Alzheimer drug as its CEO plans to step down.
Read More
Levels of Certain Thyroid Hormone May Help With Risk Stratification in MM
May 4th 2022With survival of multiple myeloma ranging from less than 1 month to over 10 years, the researchers highlighted the importance of risk stratification to quickly identify patients who are high risk with poor prognosis and could benefit from different treatment strategies and close surveillance.
Read More
Dr Soumya Vishwanath Highlights Tools for Assessing the Effectiveness of Digital Therapeutics
May 4th 2022Health plans and payers have plenty of options for how to analyze the effectiveness of digital therapeutic tools, as there are several effective strategies, according to Soumya Vishwanath, PharmD, of Magellan Rx Management.
Watch
Dr Hatem Soliman Explains Short-, Long-term Treatment Priorities for Metastatic Disease
May 3rd 2022The intent of metastatic disease treatment is palliative, not curative, so we try to prolong life and provide quality of life as much as we can, said Hatem Soliman, MD, medical director of the Clinical Trials Office, Moffitt Cancer Center.
Watch
Clinical Improvement of AERD Achieved With Dupilumab Use for Asthma, CRS With Nasal Polyps
May 3rd 2022Patients with aspirin-exacerbated respiratory disease (AERD) who initiated treatment with dupilumab as an add-on asthma or chronic rhinosinusitis with nasal polyps therapy reported rapid clinical improvement that was sustained after 3 months.
Read More
Study Calls for Sex-Specific Tactics to Reduce Rising Heart Attacks in Young Adults
May 3rd 2022These investigators wanted to better understand the reasons for the increased risk for acute myocardial infarctions among young women, who have the largest increase in hospitalization for heart attacks.
Read More
PLWH in Romania Need More Comprehensive Care, Advocate Says
May 3rd 2022Nicoleta Dascalu, founding member and advocacy manager of Asociaţia Română Anti-SIDA (ARAS; Romanian Association Against AIDS), discusses the status of care for persons living with HIV/AIDS (PLWH) in Romania, including health care coverage and lack of adequate medication access.
Watch
European Effort Will Make Cholangiocarcinoma Treatment Info Available in Multiple Languages
May 2nd 2022The project seeks to develop materials explaining chemotherapy regimens for patients with biliary tract cancers and then translate these materials into “standardized, high-quality, free, and easily accessible resources."
Read More